Research infrastructure for clinical trials of mRNA-based vaccines and/or therapeutics

Provides a single fixed grant of $5,000,000 over 3 years to an Australian organisation to use and enhance emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and/or therapeutics.

An eligible organisation who applied to the Department of Industry, Science, Energy and Resources (DISER) and Department of Health’s 'Approach To Market: Enabling Australia’s onshore mRNA manufacturing capability' program and who can partner with at least one state government partner organisation contributing to the research.

The opportunity is part of the Medical Research Future Fund (MRFF) and the Coronavirus Research response and provides funding to Australian medical research and medical innovation projects that leverage and enhance emerging technologies, platforms, equipment and infrastructure to conduct clinical trials of mRNA-based vaccines and/or therapeutics.